GSK’s Oncology Portfolio in India to be Boosted by Jemperli and Zejula
GSK's India oncology portfolio is set to receive a significant boost with the introduction of…
GSK
Asia’s Biopharma Boom: GSK, Hengrui, Novartis, and Pfizer Lead the Charge
Major pharmaceutical companies are partnering with Asian biotechs to tap into the region's innovative pipeline…
23andMe Files for Bankruptcy, Assets to be Sold to GSK Amid Financial Struggles
23andMe, a pioneer in direct-to-consumer genetic testing, has filed for bankruptcy and plans to sell…